Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2026-02-28 @ 4:57 AM
Study NCT ID:
NCT05315557
Status:
UNKNOWN
Last Update Posted:
2022-04-07
First Post:
2022-03-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial
Sponsor:
Institute of Liver and Biliary Sciences, India
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ILBS-Cirrhosis-48
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None